GlassScriptPhysician profile
Joseph J Seurer
NPI 1699932020
$905.53
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $705 · 2020: $67.13 · 2022: $133.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dynavax Technologies Corporation | $133.30 | 2022 | |
| Amgen INC. | $127.61 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $124.69 | 2019 | |
| Lilly USA, LLC | $117.41 | 2019 | |
| Sunovion Pharmaceuticals INC. | $79.80 | 2019 | |
| Pfizer INC. | $59.82 | 2019-2020 | |
| Novo Nordisk INC | $53.57 | 2019-2020 | |
| Grifols USA, LLC | $39.35 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.37 | 2019-2020 | |
| Genentech USA, INC. | $26.90 | 2019 | |
| Dexcom, INC. | $15.30 | 2019 | |
| Gilead Sciences, INC. | $14.49 | 2019 | |
| Alexion Pharmaceuticals, INC. | $14.21 | 2019 | |
| Radius Health, INC. | $12.28 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $11.84 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $11.63 | 2019 | |
| Glaxosmithkline, LLC. | $11.14 | 2019 | |
| Sanofi-Aventis U.S. LLC | $10.97 | 2019 | |
| Merck Sharp & Dohme LLC | $10.85 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Seurer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.